GlaxoSmithKline PLC — Director's Dealing 2025

May 1, 2025

National Storage Mechanism | Additional information

RNS Number : 1212H

GSK PLC

01 May 2025

Issued: 1 May 2025, London UK

Dr Gavin Screaton

GSK plc (LSE/NYSE: GSK) confirms that on joining the Board today (Thursday 1 May 2025)1 Dr Gavin Screaton holds 8,675 ordinary shares of 31 ¼ pence in the Company.

References

1.       https://www.londonstockexchange.com/news-article/GSK/directorate-change/16909060

Registered in England & Wales:

No. 3888792

Registered Office:

79 New Oxford Street

London

WC1A 1DG

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHSSUFLFEISEFI